ruxolitinib
novartis,incyte
['bet', 'rux,(-crux),(-trux)', 'rux,(-crux),(-trux),(-deruxtecan)']
brillant and intriguing presentation by polina shindiapina from on prmt5 inhib in #hlh. affects both the jak-stat and nfkb pathways. prmt5inhib seems more effective than ruxo in a relevant murine hlh-model. #ash22 #ash2022 #myashhighlights 
Just trying to be a clinician in spite of horrendous IT systems. Special interests autoimmunity,hyperinflammation (HLH), MPNs plus art,Brøndby IF and chicken